Until now, research on the effects of tea on the regulation of CYPs mainly focuses on CYP2E1 [49], while our study indicates the cyp2c subfamily as a promising target for matcha green tea to improve steatosis hepatitis. The gene discussed is CYP2E1; the disease is fatty liver disease.